1. Home
  2. CLLS vs ARQ Comparison

CLLS vs ARQ Comparison

Compare CLLS & ARQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • ARQ
  • Stock Information
  • Founded
  • CLLS 1999
  • ARQ 1996
  • Country
  • CLLS France
  • ARQ United States
  • Employees
  • CLLS N/A
  • ARQ N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • ARQ
  • Sector
  • CLLS Health Care
  • ARQ
  • Exchange
  • CLLS Nasdaq
  • ARQ NYSE
  • Market Cap
  • CLLS 143.4M
  • ARQ 155.3M
  • IPO Year
  • CLLS 2007
  • ARQ N/A
  • Fundamental
  • Price
  • CLLS $1.58
  • ARQ $5.86
  • Analyst Decision
  • CLLS Buy
  • ARQ Strong Buy
  • Analyst Count
  • CLLS 1
  • ARQ 1
  • Target Price
  • CLLS $4.00
  • ARQ $8.00
  • AVG Volume (30 Days)
  • CLLS 54.7K
  • ARQ 200.1K
  • Earning Date
  • CLLS 08-05-2025
  • ARQ 08-11-2025
  • Dividend Yield
  • CLLS N/A
  • ARQ N/A
  • EPS Growth
  • CLLS N/A
  • ARQ N/A
  • EPS
  • CLLS N/A
  • ARQ N/A
  • Revenue
  • CLLS $54,747,000.00
  • ARQ $114,466,000.00
  • Revenue This Year
  • CLLS $48.52
  • ARQ $10.91
  • Revenue Next Year
  • CLLS $5.17
  • ARQ $32.95
  • P/E Ratio
  • CLLS N/A
  • ARQ N/A
  • Revenue Growth
  • CLLS 351.26
  • ARQ 14.33
  • 52 Week Low
  • CLLS $1.10
  • ARQ $3.34
  • 52 Week High
  • CLLS $2.43
  • ARQ $8.11
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 64.58
  • ARQ 69.35
  • Support Level
  • CLLS $1.41
  • ARQ $4.91
  • Resistance Level
  • CLLS $1.65
  • ARQ $5.28
  • Average True Range (ATR)
  • CLLS 0.10
  • ARQ 0.27
  • MACD
  • CLLS 0.03
  • ARQ 0.05
  • Stochastic Oscillator
  • CLLS 93.81
  • ARQ 96.52

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

About ARQ ARQ INC

Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granula Activated Carbon, and Colloidal Carbon Product among others.

Share on Social Networks: